Literature DB >> 11278959

Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids.

A Berton1, V Rigot, E Huet, M Decarme, Y Eeckhout, L Patthy, G Godeau, W Hornebeck, G Bellon, H Emonard.   

Abstract

The matrix metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) are implicated in the physiological and pathological breakdown of several extracellular matrix proteins. In the present study, we show that long-chain fatty acids (e.g. oleic acid, elaidic acid, and cis- and trans-parinaric acids) inhibit gelatinase A as well as gelatinase B with K(i) values in the micromolar range but had only weak inhibitory effect on collagenase-1 (MMP-1), as assessed using synthetic or natural substrates. The inhibition of gelatinases depended on fatty acid chain length (with C18 > C16, C14, and C10), and the presence of unsaturations increased their inhibitory capacity on both types of gelatinase. Ex vivo experiments on human skin tissue sections have shown that micromolar concentrations of a long-chain unsaturated fatty acid (elaidic acid) protect collagen and elastin fibers against degradation by gelatinases A and B, respectively. In order to understand why gelatinases are more susceptible than collagenase-1 to inhibition by long-chain fatty acids, the possible role of the fibronectin-like domain (a domain unique to gelatinases) in binding inhibitory fatty acids was investigated. Affinity and kinetic studies with a recombinant fibronectin-like domain of gelatinase A and with a recombinant mutant of gelatinase A from which this domain had been deleted pointed to an interaction of long-chain fatty acids with the fibronectin-like domain of the protease. Surface plasmon resonance studies on the interaction of long-chain fatty acids with the three individual type II modules of the fibronectin-like domain of gelatinase A revealed that the first type II module is primarily responsible for binding these compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278959     DOI: 10.1074/jbc.M011664200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.

Authors:  Charlotte Selvais; Ludovic D'Auria; Donatienne Tyteca; Gwenn Perrot; Pascale Lemoine; Linda Troeberg; Stéphane Dedieu; Agnès Noël; Hideaki Nagase; Patrick Henriet; Pierre J Courtoy; Etienne Marbaix; Hervé Emonard
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

2.  Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9.

Authors:  Athira Omanakuttan; Jyotsna Nambiar; Rodney M Harris; Chinchu Bose; Nanjan Pandurangan; Rebu K Varghese; Geetha B Kumar; John A Tainer; Asoke Banerji; J Jefferson P Perry; Bipin G Nair
Journal:  Mol Pharmacol       Date:  2012-06-28       Impact factor: 4.436

3.  Omega-3 and Omega-6 Fatty Acids Act as Inhibitors of the Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Activity.

Authors:  Eleonora Nicolai; Federica Sinibaldi; Gianpaolo Sannino; Giuseppina Laganà; Francesco Basoli; Silvia Licoccia; Paola Cozza; Roberto Santucci; Maria Cristina Piro
Journal:  Protein J       Date:  2017-08       Impact factor: 2.371

4.  The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

Authors:  Kristopher B Deatrick; Catherine E Luke; Megan A Elfline; Vikram Sood; Joseph Baldwin; Gilbert R Upchurch; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2013-03-13       Impact factor: 4.268

Review 5.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

Review 6.  Looking Inside the Matrix: Perineuronal Nets in Plasticity, Maladaptive Plasticity and Neurological Disorders.

Authors:  Ciro De Luca; Michele Papa
Journal:  Neurochem Res       Date:  2016-03-02       Impact factor: 3.996

7.  A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.

Authors:  Hamed Kargozaran; Sarah Y Yuan; Jerome W Breslin; Katherine D Watson; Nathalie Gaudreault; Alison Breen; Mack H Wu
Journal:  Clin Exp Metastasis       Date:  2007-07-25       Impact factor: 5.150

8.  Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatment.

Authors:  Grazia Maria Liuzzi; Tiziana Latronico; Rocco Rossano; Sandra Viggiani; Anna Fasano; Paolo Riccio
Journal:  Neurochem Res       Date:  2007-07-11       Impact factor: 3.996

9.  Analysis of gene expression in PTHrP-/- mammary buds supports a role for BMP signaling and MMP2 in the initiation of ductal morphogenesis.

Authors:  Julie Hens; Pamela Dann; Minoti Hiremath; Tien-Chi Pan; Lewis Chodosh; John Wysolmerski
Journal:  Dev Dyn       Date:  2009-11       Impact factor: 3.780

10.  A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.

Authors:  Amit Gaggar; Patricia L Jackson; Brett D Noerager; Philip J O'Reilly; D Brent McQuaid; Steven M Rowe; J P Clancy; J Edwin Blalock
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.